1 |
XIA L, SUN C, ZHU H, et al. Melatonin protects against thoracic aortic aneurysm and dissection through SIRT1-dependent regulation of oxidative stress and vascular smooth muscle cell loss[J]. J Pineal Res, 2020, 69(1): e12661.
|
2 |
CHEN S Y, SHI J J, ZOU L S, et al. Quality evaluation of wild and cultivated Schisandrae Chinensis Fructus based on simultaneous determination of multiple bioactive constituents combined with multivariate statistical analysis[J]. Molecules, 2019, 24(7):1335.
|
3 |
SHI P Y, GENG Q Q, CHEN L F, et al. Schisandra chinensis bee pollen's chemical profiles and protective effect against H2O2-induced apoptosis in H9c2 cardiomyocytes[J]. BMC Complementary Med Ther, 2020, 20(1): 1-14.
|
4 |
JANG M A, LEE S J, BAEK S E, et al. A-iso-cubebene inhibits PDGF-induced vascular smooth muscle cell proliferation by suppressing osteopontin expression[J]. PLoS One, 2017, 12(1): e0170699.
|
5 |
JEONG J W, KIM J W, KU S K, et al. Essential oils purified from Schisandrae semen inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 activation and migration of human aortic smooth muscle cells[J]. BMC Complement Altern Med, 2015, 15: 7.
|
6 |
WANG F, TU Y, GAO Y, et al. Smooth muscle sirtuin 1 blocks thoracic aortic aneurysm/dissection development in mice[J]. Cardiovas Drugs Ther, 2020, 34(5): 641-650.
|
7 |
LI G, WANG M, CAULK A W, et al. Chronic mTOR activation induces a degradative smooth muscle cell phenotype[J]. J Clin Invest, 2020, 130(3): 1233-1251.
|
8 |
GILLIS E, LVAN LAER, LOEYS B L. Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-β signaling and vascular smooth muscle cell contractility[J]. Circ Res, 2013, 113(3): 327-340.
|
9 |
CHEN X L, XIAO Q L, PANG Z H, et al. Molecular mechanisms of An-Chuan Granule for the treatment of asthma based on a network pharmacology approach and experimental validation[J]. Biosci Rep, 2021, 41(3): BSR20204247.
|
10 |
HUANG B, XIONG J, ZHAO X, et al. Network pharmacology-based analysis of the pharmacological mechanisms of aloperine on cardiovascular disease[J]. Evid Based Complement Alternat Med, 2020, 2020: 5180716.
|
11 |
HUANG B, HUANG C, ZHU L, et al. Exploring the pharmacological mechanisms of tripterygium wilfordii hook F against cardiovascular disease using network pharmacology and molecular docking[J]. Biomed Res Int, 2021, 2021: 5575621.
|
12 |
LI L, YANG D, LI J, et al. Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation[J]. BMC Complement Med Ther, 2020, 20(1): 112.
|
13 |
KIRÇA M, YEŞILKAYA A. Losartan inhibits EGFR transactivation in vascular smooth muscle cells[J]. Turkish J Med Sci, 2018, 48(6): 1364-1371.
|
14 |
MUGABE B E, YAGHINI F A, SONG C Y, et al. Angiotensin II-induced migration of vascular smooth muscle cells is mediated by p38 mitogen-activated protein kinase-activated c-Src through spleen tyrosine kinase and epidermal growth factor receptor transactivation[J]. J Pharmacol Exp Ther, 2010, 332(1): 116-124.
|
15 |
SHEN Y H, ZHANG L, GAN Y, et al. Up-regulation of PTEN (phosphatase and tensin homolog deleted on chromosome ten) mediates p38 MAPK stress signal-induced inhibition of insulin signaling. A cross-talk between stress signaling and insulin signaling in resistin-treated human endothelial cells[J]. J Biol Chem, 2006, 281(12): 7727-7736.
|
16 |
LUO Z, FUJIO Y, KUREISHI Y, et al. Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo [J]. J Clin Invest, 2000, 106(4): 493-499.
|
17 |
LIU R, LO L, LAY A J, et al. ARHGAP18 protects against thoracic aortic aneurysm formation by mitigating the synthetic and proinflammatory smooth muscle cell phenotype[J]. Circ Res, 2017, 121(5): 512-524.
|
18 |
BAI Z, GU J, SHI Y, et al. Effect of inflammation on the biomechanical strength of involved aorta in type A aortic dissection and ascending thoracic aortic aneurysm: An initial research[J]. Anatol J Cardiol, 2018, 20(2): 85-92.
|
19 |
ISOLA G, POLIZZI A, RONSIVALLE V, et al. Impact of matrix metalloproteinase-9 during periodontitis and cardiovascular diseases[J].Molecules,2021,26(6): 1777.
|
20 |
YABLUCHANSKIY A, MA Y, IYER R P, et al. Matrix metalloproteinase-9: Many shades of function in cardiovascular disease[J].Physiology (Bethesda), 2013, 28(6): 391-403.
|
21 |
WANG L, ASTONE M, ALAM S K, et al. Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability[J]. bioRxiv, Mol,Biol, 2020, 28(20).DOI:10.1242/dmm.049029 .
doi: 10.1242/dmm.049029
|
22 |
HU X, MA R, CAO J,et al.PTPN2 negatively regulates macrophage inflammation in atherosclerosis[J]. Aging(Albany NY), 2020, 13(2): 2768-2779.
|
23 |
TANG H X, QIN X P, LI J. Role of the signal transducer and activator of transcription 3 protein in the proliferation of vascular smooth muscle cells[J]. Vascular, 2020, 28(6): 821-828.
|
24 |
CHUN J N, PARK S, LEE S, et al. Schisandrol B and schisandrin B inhibit TGFβ1-mediated NF-κB activation via a Smad-independent mechanism[J]. Oncotarget, 2018, 9(3): 3121-3130.
|
25 |
PICCOLO S R, SUN Y, CAMPBELL J D, et al. A single-sample microarray normalization method to facilitate personalized-medicine workflows[J]. Genomics, 2012, 100(6): 337-344.
|
26 |
章晓云, 李华南, 陈 锋, 等. 网络药理学结合分子对接技术揭示桂枝芍药知母汤治疗痛风性关节炎的潜在分子机制[J]. 中国组织工程研究, 2022, 26(2): 245-252.
|
27 |
LINDSAY M E, DIETZ H C. Lessons on the pathogenesis of aneurysm from heritable conditions[J]. Nature, 2011, 473(7347): 308-316.
|
28 |
SHI X, GUO L W, SEEDIAL S M, et al. TGF-β/Smad3 inhibit vascular smooth muscle cell apoptosis through an autocrine signaling mechanism involving VEGF-A[J]. Cell Death Dis, 2014, 5(7): e1317.
|
29 |
LIAO X H, XIANG Y, LI H, et al. VEGF-A stimulates STAT3 activity via nitrosylation of myocardin to regulate the expression of vascular smooth muscle cell differentiation markers[J]. Sci Rep, 2017, 7(1): 2660.
|
30 |
LIAO X H, WANG N, ZHAO D W, et al. STAT3 protein regulates vascular smooth muscle cell phenotypic switch by interaction with myocardin[J]. J Biol Chem, 2015, 290(32): 19641-19652.
|
31 |
WANG L, WU H, XIONG L, et al. Quercetin downregulates cyclooxygenase-2 expression and HIF-1α/VEGF signaling-related angiogenesis in a mouse model of abdominal aortic aneurysm[J]. Biomed Res Int, 2020, 2020: 9485398.
|
32 |
GEISSLER A, RYZHOV S, SAWYER D B. Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease[J]. Clin Sci (Lond), 2020, 134(19): 2623-2643.
|
33 |
SUN Y, ZHANG S, YUE M, et al. Angiotensin Ⅱ inhibits apoptosis of mouse aortic smooth muscle cells through regulating the circNRG-1/miR-193b-5p/NRG-1 axis[J]. Cell Death Dis, 2019, 10(5): 362.
|
34 |
MCCAFFREY T A. TGF-beta signaling in atherosclerosis and restenosis[J]. Front Biosci (Schol Ed), 2009, 1: 236-245.
|
35 |
RUIZ-ORTEGA M, RODRíGUEZ-VITA J, SANCHEZ-LOPEZ E, et al. TGF-beta signaling in vascular fibrosis[J]. Cardiovasc Res, 2007, 74(2): 196-206.
|
36 |
GOMEZ D, OWENS G K. Smooth muscle cell phenotypic switching in atherosclerosis[J]. Cardiovasc Res, 2012, 95(2): 156-164.
|
37 |
FISHER S A. Vascular smooth muscle phenotypic diversity and function[J]. Physiol Genomics, 2010, 42A(3): 169-187.
|
38 |
CHUN J N, KIM S Y, PARK E J, et al. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation[J]. J Ethnopharmacol, 2014, 152(2): 364-371.
|
39 |
PARK E J, CHUN J N, KIM S H, et al. Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways[J].Biochem Pharmacol,2012,83(3): 378-384.
|
40 |
BEN P, HU M, WU H, et al. L-theanine down-regulates the JAK/STAT3 pathway to attenuate the proliferation and migration of vascular smooth muscle cells induced by angiotensin Ⅱ[J]. Biol Pharm Bull, 2018, 41(11): 1678-1684.
|
41 |
DANIEL J M, DUTZMANN J, BIELENBERG W, et al. Inhibition of STAT3 signaling prevents vascular smooth muscle cell proliferation and neointima formation[J]. Basic Res Cardiol, 2012, 107(3): 261.
|
42 |
LIU C, ZHANG C C, JIA L X, et al. Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection[J]. Clin Sci, 2018, 132(6): 655-668.
|
43 |
SCHMITT R, TSCHEUSCHLER A, LASCHINSKI P,et al. A potential key mechanism in ascending aortic aneurysm development: Detection of a linear relationship between MMP-14/TIMP-2 ratio and active MMP-2[J]. PLoS One, 2019, 14(2): e0212859.
|